分段書寫3mm d pcr顱底軟骨細(xì)胞分離和培養(yǎng)_第1頁
分段書寫3mm d pcr顱底軟骨細(xì)胞分離和培養(yǎng)_第2頁
分段書寫3mm d pcr顱底軟骨細(xì)胞分離和培養(yǎng)_第3頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

WesternBlot分析COL2A1RNATotalRNAwasextractedfromCBSCsusingTrizol(TaKaRa,Japan)accordingtothemanufacturer’sspeci?cations.TheyieldofRNAwasdeterminedusingaNanoDrop2000spectrophotometer(ThermoScientific,USA),andtheintegritywasevaluatedusingagarosegelelectrophoresisstainedwithethidiumbromide.?cationwasperformedwithatwo-stepreactionprocess:reversetranscription(RT)andPCR.EachRTreactionconsistedof0.5μgRNA,2μlofPrimerScriptBuffer,0.5μlofoligodT,0.5μlofrandom6mersand0.5μlofPrimerScriptRTEnzymeMixI(TaKaRa,Japan),inatotalvolumeof10μl.ReactionswereperformedinaGeneAmp?PCRSystem9700(AppliedBiosystems,USA)for15minat37℃,followedbyheatinactivationofRTfor5sat85℃.The10μlRTreactionmixwasthendiluted×10innuclease-waterandheldat-20℃.Real-timePCRwasperformedusingLightCycler?480ⅡReal-timePCRInstrument(Roche,Swiss)with10μlPCRreactionmixturethatincluded1μlofcDNA,5μlof2×LightCycler?480SYBRGreenIMaster(Roche,Swiss),0.2μlofforwardprimer,0.2μlofreverseprimerand3.6μlofnuclease-water.Reactionswereincubatedina384-wellopticalte(Roche,Swiss)at95℃for10min,followedby40cyclesof95℃for10s,60℃for30s.Eachsamplewasrunintriplicateforysis.AttheendofthePCRcycles,meltingcurveysiswasperformedtovalidatethespeci?cgenerationoftheexpectedPCRproduct.TheprimersequencesweredesignedinthelaboratoryandsynthesizedbyGenerayBiotech(Generay,PRC)basedonthemRNAsequencesobtainedfromtheNCBIdatabase(Table1)TheexpressionlevelsofmRNAswerenormalizedtoGAPDHandwerecalculatedusingthe2-ΔΔCtmethod(LivakandSittgen,2001).表3各擴(kuò)增使用的引物序列、循環(huán)數(shù)和產(chǎn)物大Table3NucleotidesequencesoftheprimersandprobesusedforRT-產(chǎn)物大小代及傳代過程中軟骨相關(guān)Col1a1,Col2a1,Col10a1及Sox9的表達(dá)量變化。液,吹打至清亮,轉(zhuǎn)移至EP1mlTrizol200ul15s,常溫靜15min;412000g15min500ul,顛倒混勻,10mi(RNA提取效率℃12000g10min,RNA1ml75%乙醇(DEPC水配制混勻。4℃7500g離心5min,去上清,樣品干燥5-10min,用RNA-水(DEPC水1:1000稀釋)20-50ul30minNanoDrop2000分光光度計(jì)測(cè)定濃OD260/OD280RNA完整性。轉(zhuǎn)錄反應(yīng)完全后,85℃5s終止反應(yīng)。逆轉(zhuǎn)錄完畢后加入90μlNuclease-H2O稀釋至100μl在-20℃冰箱,用于后續(xù)實(shí)驗(yàn)。引物設(shè)計(jì):引物采用RocheLCPDS2軟件設(shè)計(jì)并由捷瑞生物工程合成,各擴(kuò)增使用的引物序列、循環(huán)數(shù)和產(chǎn)物大小見表3。PCRLightCycler?480SYBRGreenIMasterLightCycler?4802×LightCycler?H2O,3.6μl。PCR程序:95℃10min;95℃10s,60℃30s,40個(gè)循環(huán)。循環(huán)結(jié)束后利用熔解曲線檢測(cè)產(chǎn)物特異性,從60℃緩慢升溫至97℃,每℃5次熒光信號(hào)。相對(duì)表達(dá)量,ΔCt=Ct目的-Ct內(nèi)參,ΔΔCt=ΔCtP1-P4樣品-ΔCtP0樣品,相對(duì)表達(dá)量=2-ΔΔCt。應(yīng)用test單因素方差分析(One-wayysisofvariance,ANOVARNATotalRNAwasextractedfrom(inputthetypeofyoursamples)using(inputthekitusedforRNAextraction)accordingtothemanufacturer’sspeci?cations.TheyieldofRNAwasdeterminedusingaNanoDrop2000spectrophotometer(ThermoScientific,USA),andtheintegritywasevaluatedusingagarosegelelectrophoresisstainedwithethidiumbromide.?cationwasperformedwithatwo-stepreactionprocess:reversetranscription(RT)andPCR.EachRTreactionconsistedof0.5μgRNA,2μlofPrimerScriptBuffer,0.5μlofoligodT,0.5μlofrandom6mersand0.5μlofPrimerScriptRTEnzymeMixI(TaKaRa,Japan),inatotalvolumeof10μl.ReactionswereperformedinaGeneAmp?PCRSystem9700(AppliedBiosystems,USA)for15minat37℃,followedbyheatinactivationofRTfor5sat85℃.The10μlRTreactionmixwasthendiluted×10innuclease-waterandheldat-20℃.Real-timePCRwasperformedusingLightCycler?480ⅡReal-timePCRInstrument(Roche,Swiss)with10μlPCRreactionmixturethatincluded1μlofcDNA,5μlof2×LightCycler?480SYBRGreenIMaster(Roche,Swiss),0.2μlofforwardprimer,0.2μlofreverseprimerand3.6μlofnuclease-water.Reactionswereincubatedina384-wellopticalte(Roche,Swiss)at95℃for10min,followedby40cyclesof95℃for10s,60℃for30s.Eachsamplewasrunintriplicatefor ysis.AttheendofthePCRcycles,meltingcurveysiswasperformedtovalidatethespeci?cgenerationoftheexpectedPCRproduct.TheprimersequencesweredesignedinthelaboratoryandsynthesizedbyGenerayBiotech(Generay,PRC)basedonthemRNAsequencesobtainedfromtheNCBIdatabaseasfollows:(inputyourprimerTheexpressionlevelsofmRNAswerenormalizedto(inputthereferencegene,e.g:GAPDH,ACTB)andwerecalculatedusingthe2-ΔΔCtmethod(LivakandSittgen,TotalRNAwasisolatedusingTRIzolreagent(Invitrogen,Carlsbad,CA)accordingtothemanufacturer’sinstructions.Afterreversetranscriptionreaction,realtimereversetranscription-polymerasechainreaction(PCR)wasperformedbyaRoc

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論